BIOVIE INC
For the period ended Jun 30, 2024. Filed Sep 30, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Sep 30, 2024
BIVI$1.30-2.3%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statements of Cash Flows
| Year ended · Year ended | ||||
|---|---|---|---|---|
| June 30, 2024 · June 30, 2023 | ||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||||
| Net loss | $(32,120,533) | $(50,255,815) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Amortization of intangible assets | 229,377 | 229,377 | ||
| Stock based compensation - restricted stock units | 1,763,450 | 1,780,047 | ||
| Stock based compensation expense - stock options | 2,823,764 | 4,222,845 | ||
| Stock based compensation expense - stock issued | 72,900 | 372,500 | ||
| Amortization of financing costs | 108,751 | 170,219 | ||
| Accretion of unearned loan discount | 1,023,145 | 1,601,445 | ||
| Accretion of loan premium | 236,970 | 421,994 | ||
| Realized gain on maturity of available-for sale | (223,865) | - | ||
| Non-cash lease expense from right-of-use assets | 49,346 | 37,465 | ||
| Gain on termination of operating lease | (5,215) | - | ||
| Change in fair value of derivative liabilities | (1,816,271) | 1,437,481 | ||
| Changes in operating assets and liabilities: | ||||
| Prepaid and other assets | (101,866) | 39,915 | ||
| Accounts payable and accrued expenses | 110,653 | 1,033,455 | ||
| Operating lease liabilities | (47,245) | (38,884) | ||
| Other current liabilities | (48,385) | (1,304,925) | ||
| Net cash used in operating activities | (27,945,024) | (40,252,881) | ||
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||||
| Proceeds from (purchases of) U.S. Treasury Bills (available-for-sale) | 14,525,000 | (14,301,135) | ||
| Net cash provided by (used in) investing activities | 14,525,000 | (14,301,135) | ||
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||||
| Net proceeds from issuance of common stock | 27,802,939 | 49,465,103 | ||
| Payments of note payable | (10,000,000) | - | ||
| Proceeds from exercise of stock options | - | 2,240 | ||
| Net proceeds from issuance of common stock - Related Party | - | 5,905,840 | ||
| Net cash provided by financing activities | 17,802,939 | 55,373,183 | ||
| Net increase in cash and cash equivalents | 4,382,915 | 819,167 | ||
| Cash and cash equivalents, beginning of period | 19,460,883 | 18,641,716 | ||
| Cash and cash equivalents, end of period | $23,843,798 | $19,460,883 | ||
| SUPPLEMENTAL CASH FLOW INFORMATION: | ||||
| Cash paid for interest | $1,525,056 | $2,106,491 | ||
| SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING ACTIVITIES: | ||||
| Right-of-use assets obtained in exchange for lease obligations | $432,192 | $ | - | |
| Unrealized gain on U.S. Treasury Bills (available-for-sale) | $ | - | $176,591 | |
| Reclassification of unrealized gains on U.S. Treasury Bills (available-for-sale investments) upon settlement | $176,591 | $ | - | |
| Deemed dividend of ratchet adjustment to warrants | $886,423 | $ | - | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.